High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer - PubMed (original) (raw)
. 2012 Aug 15;131(4):E405-15.
doi: 10.1002/ijc.26444. Epub 2011 Nov 9.
Renathe Fjelldal, Knut Liestøl, Eldri U Due, Jochen B Geigl, Sabine Riethdorf, Elin Borgen, Inga H Rye, Ida J Schneider, Anna C Obenauf, Oliver Mauermann, Gro Nilsen, Ole Christian Lingjaerde, Anne-Lise Børresen-Dale, Klaus Pantel, Michael R Speicher, Bjørn Naume, Lars O Baumbusch
Affiliations
- PMID: 21935921
- DOI: 10.1002/ijc.26444
High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer
Randi R Mathiesen et al. Int J Cancer. 2012.
Abstract
The presence of disseminated tumor cells (DTCs) in bone marrow (BM) identifies breast cancer patients with less favorable outcome. Furthermore, molecular characterization is required to investigate the malignant potential of these cells. This study presents a single-cell array comparative genomic hybridization (SCaCGH) method providing molecular analysis of immunomorphologically detected DTCs. The resolution limit of the method was estimated using the cancer cell line SK-BR-3 on 44 and 244k arrays. The technique was further tested on 28 circulating tumor cells and four hematopoietic cells (HCs) from peripheral blood (n = 8 patients). The SCaCGH method was finally applied to 24 DTCs, three immunopositive cells morphologically classified as probable HCs from breast cancer patients and five HC controls from BM (n = 7 patients plus n = 1 healthy donor). The frequency of copy number changes of the DTCs revealed similarities with primary breast tumor samples. Three of the patients had available profiles for DTCs and the corresponding tumor tissue from primary surgery. More than two-third of the analyzed DTCs disclosed equivalent changes, both to each other and to the corresponding primary disease, whereas the rest of the cells showed balanced profiles. The probable HCs revealed either balanced profiles (n = 2) or changes comparable to the tumor tissue and DTCs (n = 1), indicating morphological overlap between HCs and DTCs. Similar aberration patterns were visible in DTCs collected at diagnosis and at 3 years relapse-free follow-up. SCaCGH may be a powerful tool for the molecular characterization of DTCs.
Copyright © 2011 UICC.
Similar articles
- Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing.
Demeulemeester J, Kumar P, Møller EK, Nord S, Wedge DC, Peterson A, Mathiesen RR, Fjelldal R, Zamani Esteki M, Theunis K, Fernandez Gallardo E, Grundstad AJ, Borgen E, Baumbusch LO, Børresen-Dale AL, White KP, Kristensen VN, Van Loo P, Voet T, Naume B. Demeulemeester J, et al. Genome Biol. 2016 Dec 9;17(1):250. doi: 10.1186/s13059-016-1109-7. Genome Biol. 2016. PMID: 27931250 Free PMC article. - Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S, Pantel K. Riethdorf S, et al. Pathobiology. 2008;75(2):140-8. doi: 10.1159/000123852. Epub 2008 Jun 10. Pathobiology. 2008. PMID: 18544969 Review. - Detection of minimal residual disease in blood and bone marrow in early stage breast cancer.
Krishnamurthy S, Cristofanilli M, Singh B, Reuben J, Gao H, Cohen EN, Andreopoulou E, Hall CS, Lodhi A, Jackson S, Lucci A. Krishnamurthy S, et al. Cancer. 2010 Jul 15;116(14):3330-7. doi: 10.1002/cncr.25145. Cancer. 2010. PMID: 20564098 - Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer.
Naume B, Synnestvedt M, Falk RS, Wiedswang G, Weyde K, Risberg T, Kersten C, Mjaaland I, Vindi L, Sommer HH, Sætersdal AB, Rypdal MC, Bendigtsen Schirmer C, Wist EA, Borgen E. Naume B, et al. J Clin Oncol. 2014 Dec 1;32(34):3848-57. doi: 10.1200/JCO.2014.56.9327. Epub 2014 Nov 3. J Clin Oncol. 2014. PMID: 25366688 Clinical Trial. - Role of circulating tumor cells and disseminated tumor cells in primary breast cancer.
Hayashi N, Yamauchi H. Hayashi N, et al. Breast Cancer. 2012 Apr;19(2):110-7. doi: 10.1007/s12282-011-0282-5. Epub 2011 Jun 4. Breast Cancer. 2012. PMID: 21643809 Review.
Cited by
- Single-Cell Analysis of Bone-Marrow-Disseminated Tumour Cells.
So KWL, Su Z, Cheung JPY, Choi SW. So KWL, et al. Diagnostics (Basel). 2024 Sep 29;14(19):2172. doi: 10.3390/diagnostics14192172. Diagnostics (Basel). 2024. PMID: 39410576 Free PMC article. Review. - Microfluidic Isolation of Disseminated Tumor Cells from the Bone Marrow of Breast Cancer Patients.
Volmer LL, Önder CE, Volz B, Singh AR, Brucker SY, Engler T, Hartkopf AD, Koch A. Volmer LL, et al. Int J Mol Sci. 2023 Sep 11;24(18):13930. doi: 10.3390/ijms241813930. Int J Mol Sci. 2023. PMID: 37762233 Free PMC article. - Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments.
Mieczkowska IK, Pantelaiou-Prokaki G, Prokakis E, Schmidt GE, Müller-Kirschbaum LC, Werner M, Sen M, Velychko T, Jannasch K, Dullin C, Napp J, Pantel K, Wikman H, Wiese M, Kramm CM, Alves F, Wegwitz F. Mieczkowska IK, et al. Cell Death Dis. 2021 Nov 29;12(12):1118. doi: 10.1038/s41419-021-04407-y. Cell Death Dis. 2021. PMID: 34845197 Free PMC article. - Biphasic α2β1 Integrin Expression in Breast Cancer Metastasis to Bone.
Moritz MNO, Merkel AR, Feldman EG, Selistre-de-Araujo HS, Rhoades Sterling JA. Moritz MNO, et al. Int J Mol Sci. 2021 Jun 27;22(13):6906. doi: 10.3390/ijms22136906. Int J Mol Sci. 2021. PMID: 34199096 Free PMC article. - The emerging role of circulating tumor cells in cancer management.
Li XY, Dong M, Zang XY, Li MY, Zhou JY, Ma JJ, Wang GY. Li XY, et al. Am J Transl Res. 2020 Feb 15;12(2):332-342. eCollection 2020. Am J Transl Res. 2020. PMID: 32194887 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical